The bloodborne chemical signal sphingosine-1-phosphate (S1P) is released by blood cells to regulate immune and vascular functions. How S1P is released to the circulation was unknown for a long time, until now. Researchers reported online in the prestigious journal Nature that they had discovered this pathway in blood cells.
S1P is required as an extracellular signal for the trafficking of immune cells such as T and B cells in the circulation. These cells are part of the adaptive immune response, an important component of normal immunity. However, they become detrimental in conditions such as autoimmune and inflammatory diseases. Blocking of the S1P signalling pathway with fingolimod phosphate, a chemical compound that is analogous to S1P, has been successfully used in the treatment of multiple sclerosis.
Lack of S1P signalling is also harmful to blood vessels, often resulting in vascular complications such as cardiovascular diseases and stroke. In the study, the researchers discovered the way blood cells produce S1P for signalling roles. They found that mice lacking the major facilitator superfamily transporter 2b (Mfsd2b) protein in their blood cells had low levels of S1P in the circulation, which resulted in an abnormally low circulating lymphocyte count and increased sensitivity to shock. Their breakthrough findings pave the way for the manipulation of circulating S1P levels for the treatment of inflammatory and vascular diseases.
Surprisingly, they also found that mice that lack Mfsd2b exhibited low red blood cell counts and were sensitive to chemotherapy and radiotherapy. This implies that increasing plasma S1P levels could be beneficial to cancer patients receiving chemotherapy and radiotherapy treatments.
For a long time, researchers have suspected that hematopoietic cells constitute the major S1P supplier to the circulation. However, the molecular transport machinery was missing, making it a daunting task to understand the roles of this chemical signal in circulation. "Our study identified a critical molecular target for sphingosine-1-phosphate production," explains the senior author. "This opens up new avenues of investigation aimed at regulating sphingosine-1-phosphate signalling for the treatment of various diseases."
https://www.nature.com/nature/journal/vaop/ncurrent/full/nature24053.html
Pathway by which blood cells release a potent signaling factor revealed!
- 1,278 views
- Added
Edited
Latest News
How brains convert sounds t…
By newseditor
Posted 12 May
Mice with traits of Tourett…
By newseditor
Posted 11 May
Intermittent fasting protec…
By newseditor
Posted 11 May
Microfluidic systems resemb…
By newseditor
Posted 11 May
Neurotransmitter classifica…
By newseditor
Posted 11 May
Other Top Stories
Immune system targets vitamin B12 pathway to neutralize bacteria
Read more
A new mechanism for Chlamydia to enter human cells
Read more
How malaria parasite controls expression of proteins during the lif…
Read more
How potent bacterial toxin kills MRSA bacteria
Read more
Lifestyle is a threat to gut bacteria!
Read more
Protocols
Improved detection of DNA r…
By newseditor
Posted 09 May
Single-cell adhesive profil…
By newseditor
Posted 07 May
Parasympathetic neurons der…
By newseditor
Posted 07 May
Non-invasive measurements o…
By newseditor
Posted 05 May
A validation strategy to as…
By newseditor
Posted 04 May
Publications
Differential representation…
By newseditor
Posted 12 May
Glucose hypometabolism prom…
By newseditor
Posted 12 May
Organellophagy regulates ce…
By newseditor
Posted 12 May
Decoding mitochondria's rol…
By newseditor
Posted 11 May
APOE2 gene therapy reduces…
By newseditor
Posted 11 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar